These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35266446)

  • 1. Long noncoding RNA LINC01426 promotes the progression of lung adenocarcinoma via regulating miRNA-125a-5p/ casein kinase 2 alpha 1 axis.
    Zhu X; Zhao J; Xu J
    Bioengineered; 2022 Mar; 13(3):7020-7033. PubMed ID: 35266446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
    Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
    Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
    Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
    J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
    Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
    Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
    Wang Y; Mei X; Song W; Wang C; Qiu X
    BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA CYTOR promotes lung adenocarcinoma gemcitabine resistance and epithelial-mesenchymal transition by sponging miR-125a-5p and upregulating ANLN and RRM2.
    Cao Q; Wang H; Zhu J; Qi C; Huang H; Chu X
    Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):210-222. PubMed ID: 38273783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01426 Triggers Growth and Metastasis of Lung Adenocarcinoma as a Prognostic Indicator.
    Deng Y; Cai S; Liu W; Yang C; Guo X
    Biomed Res Int; 2022; 2022():6175053. PubMed ID: 35620225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA RP11-89K21.1 Interacts with miR-146a/b-5p to Promote Proliferation and Gefitinib Resistance Through Regulating RHPN2 and RhoA/ROCK Pathway in Lung Adenocarcinoma.
    Chen H; Shen D; Zhu F; Ou Q; Cheng L; Zhu Y
    Cancer Biother Radiopharm; 2023 Jun; 38(5):282-292. PubMed ID: 33877886
    [No Abstract]   [Full Text] [Related]  

  • 10. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
    Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
    Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC01572 promotes the malignant progression of lung adenocarcinoma by modulating p53 mediated by miRNA-338-5p/TTK axis.
    Liu S; Liu X; Yang Q; Zeng C; Hu G; Ren B
    J Pharm Pharmacol; 2024 Jul; 76(7):873-883. PubMed ID: 38698658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXA1-induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF-β signaling pathway.
    Wei J; Yu H; Liu T; Wang Z; Lang C; Pan Y
    Thorac Cancer; 2023 Jul; 14(21):2026-2037. PubMed ID: 37277890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of Lung Adenocarcinoma].
    Xu J
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):721-731. PubMed ID: 37989335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-125a-5p upregulation suppresses the proliferation and induces the cell apoptosis of lung adenocarcinoma by targeting NEDD9.
    Zheng H; Wu J; Shi J; Lu C; Wang Y; Sun Q; Zhang G; Zhao G
    Oncol Rep; 2017 Sep; 38(3):1790-1796. PubMed ID: 28714018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P; Hong X; Chang L; Xing L; Zhang H
    Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00511 enhances LUAD malignancy by upregulating GCNT3 via miR-195-5p.
    Zhang Y; Xiao P; Hu X
    BMC Cancer; 2022 Apr; 22(1):389. PubMed ID: 35399076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of LINC01426 promotes the progression and stemness in lung adenocarcinoma by enhancing the level of SHH protein to activate the hedgehog pathway.
    Liu X; Yin Z; Xu L; Liu H; Jiang L; Liu S; Sun X
    Cell Death Dis; 2021 Feb; 12(2):173. PubMed ID: 33568633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis.
    Zhu C; Wang S; Zheng M; Chen Z; Wang G; Ma J; Zhang B; Huang W; Sun X; Wang C
    Strahlenther Onkol; 2022 Mar; 198(3):304-314. PubMed ID: 35037949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.